Patent Law Weblog
recent posts
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
- Meanwhile, Back at the PTAB with CRISPR – Update
about
Category: Patentable Subject Matter
-
Congressman Becerra Once Again Tries to Ban Gene Patenting by Statute By Kevin E. Noonan — When last we encountered Congressman Xavier Becerra (D-CA), he was rumored to be headed for a post as U.S. Trade Representative (see "Proponent of Gene Patent Ban to Leave Congress"). That seems to have fallen through, because the…
-
By Donald Zuhn — Last week, the District Court for the Southern District of New York ruled in favor of the plaintiffs in Association of Molecular Pathology v. U.S. Patent and Trademark Office, finding the claims of several patents directed to the BRCA1 and BRCA2 genes invalid as encompassing non-statutory subject matter (see "Round…
-
By Donald Zuhn — On Sunday, the CBS news program "60 Minutes" examined the issue of gene patenting in a segment entitled "Patented Genes." During the segment, CBS News correspondent Morley Safer interviewed Lisbeth Ceriani and Genae Girard, who were recently diagnosed with breast cancer and who are plaintiffs in the Association of Molecular…
-
On Sunday, April 4, 2010, the CBS news program "60 Minutes" will take a look at the issue of gene patenting in a segment entitled "Patented Genes." According to the program's website, the segment will examine the question of whether "companies [should] be able to own human genes," and "the idea of biotech firms patenting…
-
By Donald Zuhn — On Monday, the District Court for the Southern District of New York ruled in favor of the plaintiffs in Association of Molecular Pathology v. U.S. Patent and Trademark Office, finding the claims of several patents directed to the BRCA1 and BRCA2 genes invalid as encompassing non-statutory subject matter (see "Round…
-
Association of Molecular Pathology v. U.S. Patent and Trademark Office By Kevin E. Noonan — Not surprisingly, Judge Robert W. Sweet of the Southern District of New York ruled in favor of the plaintiffs today in Association of Molecular Pathology v. U.S. Patent and Trademark Office, granting partial summary judgment that the claims of…
-
By Donald Zuhn — Last week, the Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) issued its long-awaited report on gene patents. While the report, entitled "Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests," indicates that gene patents and licensing practices concerning such patents have not had…
-
By Donald Zuhn — In January, the gene patenting debate returned to National Public Radio when WBUR's "On Point" became the fourth NPR program to tackle the issue since last May, when a group of patients, physicians, academic researchers, and medical societies filed suit against the U.S. Patent and Trademark Office and Myriad Genetics,…
-
By Kevin E. Noonan — Newsweek has always been Avis to Time Magazine's Hertz — evidenced by an increasing difference in subscriptions (3.3 million versus 1.97 million on 2009). So it isn't surprising that the magazine needs to do something to tweak its readership, even if that something is to distort its reporting on…
-
By Donald Zuhn — In a press conference held earlier today, the Biotechnology Industry Organization (BIO) expressed concern about recommendations to be issued on Friday with a report on gene patents. The report, entitled "Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests," is being issued by the Secretary's…
Patent Docs 